Trends in complete blood count values during acute painful episodes in children with sickle cell disease

Eufemia Jacob1, Christine Miaskowski, Marilyn Savedra

  • 1Pediatric Oncology, Baylor College of Medicine, Texas Children's Cancer Center and Hematology Service, 6701 Fannin, suite 1400, MC 3-3320, Houston, TX 77030, USA. exjacob@texaschildrenshospital.org

Insights

Complete blood count (CBC) values indicate sickle cell disease (SCD) complications. While CBC trends mirrored early healing during painful episodes, moderate pain persisted despite resolving hemolytic and inflammatory markers.

Area of Science:

  • Pediatrics
  • Hematology
  • Pain Management

Background:

  • Complete blood count (CBC) values are used to assess hemolytic and inflammatory processes in children with sickle cell disease (SCD) during acute painful episodes.
  • Understanding the relationship between CBC trends and pain intensity is crucial for managing vaso-occlusive crises.

Purpose of the Study:

  • To examine trends in CBC values during hospitalization for vaso-occlusive episodes in children with SCD.
  • To determine the relationship between CBC values and patient-reported pain intensity scores.

Main Methods:

  • Prospective study involving hospitalized children (5-19 years) with SCD admitted for vaso-occlusive pain.
  • Daily CBC values were collected from the hospital information system.
  • Patient pain intensity was assessed nightly using the African American Oucher pain scale.

Main Results:

  • Parallel changes in CBC values and pain intensity scores were observed within the first 48 hours of hospitalization.
  • Despite resolution of hemolytic and inflammatory processes indicated by CBC trends, moderate pain persisted throughout the hospitalization period.

Conclusions:

  • CBC values show parallel trends with pain intensity in the initial phase of vaso-occlusive crises in children with SCD.
  • Persistent moderate pain despite resolving inflammatory and hemolytic markers suggests a complex pain experience in SCD that requires further investigation beyond CBC monitoring.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...